Back to Journals » OncoTargets and Therapy » Volume 13
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,752 | Dovepress* | 5,083+ | 735 | 5,818 | |
PubMed Central* | 669 | 158 | 827 | ||
Totals | 5,752 | 893 | 6,645 | ||
*Since 2 October 2020 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar